Skystar BIO-Pharmaceutical CO
SEC CIK 1076939 · SKBO · last insider filing 2015-05-28
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| LU Weibing | Director · Chief Executive Officer | filed 2012 - 2014 |
| Cramer Russell Scott | Director | filed 2012 - 2012 |
| Fan Qiang | Director | filed 2008 - 2012 |
| Shen Weirong | Director | filed 2012 - 2012 |
| WEN WEI | Director · Vice President, Secretary | filed 2012 - 2012 |
| Chen Mark D | Director | filed 2009 - 2012 |
| Zhao Shouguo | Director | filed 2008 - 2008 |
| Qu Chengtun | Director | filed 2008 - 2008 |
| Yen Winston C | Director | filed 2008 - 2008 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Mei Bing | Chief Financial Officer | filed 2011 - 2014 |
| Lan Michael Hongjie | Chief Financial Officer | filed 2010 - 2010 |
| Tchaikovsky Bennet Price JR | Chief Financial Officer | filed 2008 - 2009 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.